Willemijn S M E Theelen (W S M E Theelen)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Transcription Factor

Clinical Practice

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Karlijn Hummelink, Renaud Tissier, Linda J W Bosch, Oscar Krijgsman, Michel van den Heuvel, Willemijn S M E Theelen, Diane Damotte, Francois Goldwasser, Karen Leroy, Egbert F Smit, Gerrit A Meijer, Daniela S Thommen, Kim Monkhorst
A dysfunctional T cell gene signature for predicting non-response to PD-1 blockade in non-small cell lung cancer that is suitable for routine clinical diagnostics. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Ferry Lalezari, Dennis Peters, Willemijn S M E Theelen, Viktor Hendrik Koelzer, Kirsten D Mertz, Alfred Zippelius, Michel van den Heuvel, Annegien Broeks, John B A G Haanen, Ton N M Schumacher, Gerrit A Meijer, Egbert F Smit, Kim Monkhorst, Daniela S Thommen
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Willemijn S M E Theelen, O Krijgsman, K Monkhorst, T Kuilman, D D G C Peters, S Cornelissen, M A Ligtenberg, S M Willems, J L G Blaauwgeers, C J M van Noesel, D S Peeper, M M van den Heuvel, K Schulze
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma. Journal of translational medicine 18 (1) (2020)